Status:
RECRUITING
Effect of MIT for CI With Anxiety
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Chronic Insomnia
Anxiety Disorders
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
This randomized controlled trial aims to investigate the efficacy of Mindfulness Intervention Therapy (MIT) in treating Chronic Insomnia (CI) comorbid with anxiety symptoms.
Eligibility Criteria
Inclusion
- Diagnosed with Insomnia Disorder according to DSM-5 criteria.
- Pittsburgh Sleep Quality Index (PSQI) total score \> 5.
- Age 8 years or older.
- Educational level of at least junior high school.
- Voluntarily agree to participate and provide written informed consent.
- Presence of anxiety symptoms, defined as Hamilton Anxiety Rating Scale (HAMA) score ≥ 14.
Exclusion
- Presence of severe physical illnesses or major psychiatric disorders, or at risk of suicide.
- Diagnosed or suspected of having sleep breathing disorders, restless legs syndrome, circadian rhythm sleep disorders, or engaged in shift work.
- Pregnant or breastfeeding women.
- Currently undergoing any psychological therapy.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06969053
Start Date
November 1 2024
End Date
November 1 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, China, 100053